drugset / Trial / NCT06057948
A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to test which treatment schedule of β-glucan with bivalent vaccine is more effective for participants with high-risk neuroblastoma that is in complete remission.
Timeline
- Start
- 2023-09-21
- Primary completion
- 2027-03-21
- Completion
- 2027-03-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | β-glucan | Other / unclassified | 40 mg/kg | Oral |
| Background | OBI-821 | Other / unclassified | — | — |